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abstract
Purpose: To explore public attitudes towards modifying frequency of mammography screening based on
genetic risk.
Methods: Home-based interviews were carried out with a population-based sample of 942 women aged
18e74 years in the UK. Demographic characteristics and perceived breast cancer (BC) risk were examined
as predictors of support for risk-stratiﬁed BC screening and of the acceptability of raised or lowered
screening frequency based on genetic risk, using multivariate logistic regression.
Results: Over two-thirds of respondents (65.8%) supported the idea of varying screening frequency on
the basis of genetic risk. The majority (85.4%) were willing to have more frequent breast screening if they
were found to be at higher risk, but fewer (58.8%) were willing to have less frequent screening if at lower
risk (t (956) ¼ 15.6, p < 0.001). Ethnic minority status was associated with less acceptability of more
frequent screening (OR ¼ 0.40, 95% CI ¼ 0.21e0.74), but there were no other signiﬁcant demographic
correlates. Higher perceived risk of BC was associated with greater acceptability of more frequent
screening (OR ¼ 1.71, 95%CI ¼ 1.27e2.30).
Conclusion: Women were positive about adjusting the frequency of mammography screening in line
with personal genetic risk, but it will be important to develop effective communication materials to
minimise resistance to reducing screening frequency for those at lower genetic risk.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Breast cancer screening by mammography has been identiﬁed
as reducing deaths from breast cancer; nonetheless, false positives,
overdiagnosis and overtreatment have all been identiﬁed as po-
tential harms [1,2]. Routine screening is usually recommended for
women above age 50 [http://www.cancerscreening.nhs.uk/; http://
www.who.int/cancer/detection/variouscancer/en/; http://www.
cdc.gov/cancer/dcpc/prevention/screening.htm]; although women
with a strong family history of breast cancer may be offered
screening from an earlier age [3] http://www.cancerscreening.nhs.
uk/; http://www.cdc.gov/cancer/dcpc/prevention/screening.htm).
However, approximately 20% of all breast cancers occur in women
younger than age 50 [4]; with a substantial proportion in women
without a family history. These cancers tend to be aggressive with a
poorer prognosis [5,6], and therefore early identiﬁcation, irre-
spective of known family history, might be beneﬁcial.
Given the number of genetic markers for breast cancer risk that
have been identiﬁed [7e9], incorporating genetic risk assessment
into current mammography screening has been proposed as one
way to maximise beneﬁts and minimise harms [10]. Modifying
screening eligibility and frequency to account for genetic risk could
makeit possible to‘tailor’ screening and risk managementeffortsto
those at the highest risk, for example by shortening screening in-
tervals, or byoffering screening using alternative modalities such as
Magnetic Resonance Imaging (MRI) and ultrasound. At the same
time, it would minimise exposure to potential harms of screening
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or by making a recommendation against routine mammography
screening in this group. Risk-stratiﬁed mammography screening
based on genetic risk could therefore be superior to current age-
stratiﬁed approaches [11,12].
However, implementation of genomic risk-stratiﬁed breast
screening would require the support of the wider public. The public
is generally very enthusiastic about screening [13,14]. Women
perceive high beneﬁts of mammography screening [15,16]; re-
ﬂected in the high attendance rates (around 70%) across countries
[17e19]; although lower socioeconomic status (SES) and ethnic
minority status have both been associated with lower participation
rates [20e22]. Perceived risk of breast cancer has been cited as
encouraging some individuals to be screened, while deterring
others [16,23,24]; so predicting the impact of giving genetic risk
information on screening uptake is difﬁcult. There has also been
attention to public perceptions of a ‘right to be screened’, which
may militate against the acceptability of reducing breast screening
frequency for those at the lowest risk.
Few studies to date have investigated public attitudes to ‘per-
sonalised’ cancer screening, despite calls for empirical research on
the topic [10,25]. One qualitative study in the Netherlands found
that women were supportive of both increases and reductions in
breast screening frequency, although there was an important pro-
viso that any woman who was worried about breast cancer despite
having lowgenetic risk, should still be able to access screening [26].
A small qualitative study in the UK found enthusiasm for risk-
stratiﬁed ovarian cancer screening based on genetic risk [27], but
these ﬁndings cannot be assumed to generalise to an existing and
very popular mammography breast screening programme; espe-
cially given evidence from two studies that show that information
on overdiagnosis is not a deterrent for mammographyscreening for
most women [14,28].
Given that research is under way to test the feasibility of
‘personalising’ mammography screening based on individual risk
factors, including genetic risk [29], the primary aim of this study
was to investigate public attitudes towards amending the fre-
quency of breast cancer screening based on genetic risk in the
current UK National Health Service Breast Cancer Screening Pro-
gramme. Data were from a large, population-based study, making
it possible to identify demographic and personal predictors of
support for raising or lowering frequency of cancer screening
based on genetic risk.
Methods and procedure
Sample
Data were collected by adding a question module on ‘genetics
and screening’ to the ‘Opinions and Lifestyle’ survey, which is
conducted monthly by the UK Ofﬁce of National Statistics (ONS) on
behalf of government departments, non-governmental agencies
and academic institutions. Each month, 2010 households are
identiﬁed from the Royal Mail's Postcode Address File using strat-
iﬁed random probability sampling. Selected addresses are con-
tacted up to eight times at different times and days of the week to
maximize response rates. One person aged over 16 from each
household is randomly chosen to complete a computer-assisted
face-to-face interview with trained researchers. Questions on the
‘genetics and screening’ module were included in two data
collection waves, January and March 2014. Although questions
were read out, we used the Flesch Reading Ease formula and the
Flesch-Kincaid Grade Level formula to estimate comprehension.
This produced a score of 68; conferring a reading level expected in
grade 6 (age 12).
Measures
The module was introduced with a short explanation about
genes and risk-stratiﬁed cancer screening that had been agreed
with ONS: ‘Genes contain the ‘instruction manual’ of life, called
DNA. Genes are passed from parents to their children. Nowadays,
it is possible to predict whether someone is likely to develop
certain diseases by looking at their genes. This is called genetic
testing’. No information was given on current breast cancer
screening approaches or potential harms of screening.
Outcome variables
One question addressed attitudes to risk-stratiﬁed breast cancer
screening: ‘It is possible that breast screening frequency could be
varied depending on whether a woman is at higher or lower genetic
risk of breast cancer. What do you think of the idea of varying the
frequency of breast screening’ (‘very bad idea’; ‘bad idea’; ‘not sure’;
‘good idea’; ‘very good idea’). Responses were dichotomized into
very bad idea/bad idea/not sure vs. good idea/very good idea to
reﬂect not supporting vs. supporting personalized risk-stratiﬁed
breast cancer screening.
Personal acceptability of modiﬁed breast screening frequency
was assessed with two questions: ‘Would you personally be happy to
have your breast screening more often if you were found to be at
higher genetic risk of breast cancer’, and ‘Would you personally be
happy to have your breast screening less often if you were found to be
at lower genetic risk of breast cancer’ (‘very unhappy’; unhappy’; ‘not
sure’; ‘happy’ and ‘very happy’). For some analyses, very unhappy/
unhappy/not sure were combined for comparison with happy/very
happy to reﬂect lowand high acceptability of varying the frequency
of breast cancer screening.
Attitudes towards genetic testing generally were assessed to be
sure that acceptability of stratiﬁed screening was not inﬂuenced by
views about genetic testing, using the question: ‘Based onwhat you
know, do you think genetic testing will do more good than harm, or
more harm than good? Response options were ‘Do more good than
harm’, ‘do more harm than good’, ‘not sure/it depends’ and ‘Ih a v e
never heard of genetic testing’. Responses were coded as ‘Do more
good than harm’ vs. ‘do more harm than good/it depends’. Participants
who responded that they had never heard of genetic testing were
excluded from further analyses (n ¼ 14). This question was taken
from previous surveys that investigated public attitudes to genetic
testing [30,31].
Predictor variables
Perceived relative risk of breast cancer was assessed with one
question: ‘Compared with other women of your age, what do you
think are your chances of getting breast cancer’ with response op-
tions of: ‘much lower than others’, ‘lower than others’, ‘the same as
others’, ‘higher than others’, ‘much higher than others’. For the current
analyses, we treated this variable as continuous, so as to not lose
power.
Demographic data were provided by ONS from their standard
survey items (http://www.ons.gov.uk/ons/%20ons/index.html).
Age was coded as  50 vs. >50 years; women >50 years could
have already been invited for breast screening, as part of the
national breast screening programme in the UK. Ethnicity was
classiﬁed as ‘White’ vs. ‘ethnic minority’ because the individual
ethnic minority sub-groups were small. Educational attainment
was classiﬁed as university degree or equivalent vs. below uni-
versity degree level. Marital status was coded as married/
cohabiting vs. single/widowed/divorced. Unfortunately, we had
no information on past uptake of screening; or family history of
breast cancer.
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We included women aged 18e74 to reﬂect the population who
could be eligible for risk-stratiﬁed breast cancer screening. Sta-
tistical analyses were carried out using the Statistical Package for
Social Sciences (SPSS) version 20.0 (SPPS Inc., Chicago, IL). We
explored demographic and personal predictors for each outcome
variable in univariate c2 analyses. Multivariate logistic regression
was used to establish the associations of all described de-
mographic characteristics and beliefs about genetic testing; as
well as attitudes to risk-stratiﬁed mammography screening. Ana-
lyses were repeated including perceived risk. Bonferroni correc-
tions were employed to correct for multiple testing and a was set
at 0.05/5 ¼ 0.01.
Results
In the January wave, 8% (n ¼ 166) of the 2010 selected
households were not eligible because they were businesses or
empty properties. Of 1844 eligible households, 9% (n ¼ 171)
could not be contacted and 33% (n ¼ 608) declined to take part in
the ONS survey. In the March wave, 1853 households were
eligible (92%). Of those, 13% (n ¼ 237) could not be contacted and
31% (n ¼ 578) chose not to take part. Therefore, the overall
response rate was 57%; comparable to previous ONS surveys
(http://www.ons.gov.uk/ons/index.html). The ﬁnal female sam-
ple was n ¼ 1095.
After excluding individuals ineligible by age (aged below 18
years and above 74 years; n ¼ 138), or missing data (n ¼ 15) the
ﬁnal sample for analysis consisted of 942 women aged 18e74
(mean 47 years; SD ¼ 15.6). Most were ‘White’ (92.8%, n ¼ 874),
over half were married or cohabiting (54.1%, n ¼ 510), and over a
quarter (26.8%, n ¼ 252) were at least university educated. In
common with other survey studies [32], education was higher in
the sample than in the general population; other demographic
characteristics were comparable to the UK population of women
aged 18e74 (ONS Census 2011: (http://www.ons.gov.uk/ons/guide-
method/census/2011/index).
Most women (67.7%) held the belief that ‘genetic testing
causes more good than harm’,7 . 4 %b e l i e v e dt h a ti t‘causes more
harm than good’, and 23.5% thought that ‘it depends’. The belief
that ‘genetic testing causes more harm than good’ was unrelated
to any demographic factors or to perceived risk (data not
shown).
Attitudes to risk-stratiﬁed breast cancer screening
Over two thirds of respondents (65.8%) thought that varying the
frequency of breast cancer screening to take into account personal
genetic risk was a ‘good’ or ‘very good’ idea. Other respondents
rated it as ‘bad (13.4%), ‘very bad’ (4.0%), or were ‘not sure’ (16.8%).
The majority (85.4%) would be willing to have more frequent
breast screening if they were found to be at higher risk. Signiﬁ-
cantly fewer women (58.8%) would be willing to have less frequent
breast screening if they were found to be at lower risk (t
(956) ¼ 15.6, p < 0.001) (See Table 1).
Women with university education were more supportive of
varying breast cancer screening frequency in univariate analyses
(p ¼ 0.023), but the association became non-signiﬁcant after
adjustment for covariates and multiple testing (p ¼ 0.121) (see
Table 2). Ethnic minority status was associated with less positive
attitudes towards more frequent screening at a higher genetic risk
in univariate and multivariate analyses.
The impact of perceived risk on attitudes to risk-stratiﬁed breast
cancer screening
Of 858 women who answered the question on perceived breast
cancer risk, 16.5% (n ¼ 135) felt at ‘much lower’ or ‘lower risk’ of
breast cancer, most felt that their risk was ‘the same’ (73.5%,
n ¼ 631), and very few women felt that they were at ‘higher’ or
‘much higher’ risk of breast cancer (9.9%, ¼ 85) than other women
of their age group (mean score: 2.91, SD ¼ 0.6). Higher perceived
risk of breast cancer was associated with more positive attitudes
towards more frequent breast cancer screening in the multivariate
analysis, but had no impact on attitudes towards varying screening
Table 1
Univariate analyses (c
2-test) of support of risk-stratiﬁed breast cancer screening.
Variable Good/very good idea (vs. bad/very
bad idea/not sure) to vary frequency
of BC screening by risk
Happy/very happy (vs. very unhappy/
unhappy/not sure) to have more frequent
BC screening if at higher risk
Happy/very happy (vs. very unhappy/
unhappy/not sure) to have less
frequent BC screening if at lower risk
% (n) p-value % (n) p-value % (n) p-value
Total (n ¼ 942) 65.8 (619) 85.4 (804) 58.8 (554)
Age
>50 67.6 (354) 0.125 84.4 (352) 0.395 56.2 (235) 0.225
 50 63.2 (264) 86.1 (452) 60.9 (319)
Ethnicity
White 65.7 (576) 0.862 86.3 (757) 0.002 58.7 (515) 0.840
Ethnic minority 64.6 (42) 72.3 (47) 60.0 (39)
Education
University degree 71.4 (180) 0.023 87.4 (222) 0.279 63.6 (161) 0.068
Below university degree 63.5 (438) 84.6 (582) 57.0 (393)
Marital status
Married/cohabiting 64.6 (329) 0.497 85.5 (435) 0.917 59.1 (300) 0.869
Single/widowed/divorced 66.7 (289) 85.2 (369) 58.5 (254)
Perceived risk of breast cancer(n ¼ 858)
Much lower than others 76.9 (21) 0.297 63.0 (19) 0.002 66.7 (19) 0.875
Lower than others 73.7 (85) 79.8 (91) 62.3 (71)
The same as others 65.1 (410) 86.0 (542) 59.7 (377)
Higher than others 69.3 (52) 90.7 (68) 58.7 (44)
Much higher than others 60.0 (6) 100.0 (10) 70.0 (7)
Notes: Abbreviations: BC ¼ Breast cancer.
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at lower risk (Table 2).
Discussion
This is the ﬁrst population-based study investigating
women's attitudes to risk-stratiﬁed mammography screening
based on genetic risk assessment. Although the majority of
women were enthusiastic about a risk-stratiﬁed approach to
breast screening, this was particularly with respect to increasing
screening frequency for those at higher genetic risk. Fewer were
supportive of a reduction in screening frequency for those at
lower risk.
Since most women were of the opinion that genetic testing
would ‘cause more good than harm’, it is unlikely that the different
reactions to more vs. less frequent screening are related to the use
of genetic testing per se, and more likely they are due to the
perceived beneﬁts of mammography screening. One possibility is
that it reﬂects a notion of an ‘acquired right’ to screening, as
described by Henneman and colleagues [26]. Studies of attitudes to
overdiagnosis [28,33] suggest that many women take a ‘better safe
than sorry’ approach to cancer screening; making them more
accepting of false-positive results and over-diagnosis. Further
research is needed to explore the reasons behind this ﬁnding and
discover how to best communicate any changes to breast screening
recommendations.
Ethnic minority status was associated with negative attitudes
towards attending screening more frequently with a higher genetic
risk, although there was no relationship with attitudes towards
risk-stratiﬁed screening in general, or towards reducing screening
frequency for those at lower risk. This suggests that the prospect of
more frequent mammography screening may be problematic for
some subgroups. Breast screening attendance has historically been
lower for women from ethnic minority groups [34], with notions of
privacy and modesty found to be barriers to breast screening
participation [35,36]. Furthermore, cancer fatalism (i.e. the belief
that cancer is inevitable) is higher in some ethnic groups, which has
also been suggested as a reason to forego breast cancer screening
[37,38]. However, the small numbers of ethnic minority women in
the present sample e approximately reﬂecting population levels e
made it impossible to compare individual ethnic groups. This could
be explored in future research.
Although perceived risk was associated with more positive at-
titudes to more frequent breast-screening, it was not associated
with any other variables. This replicates ﬁndings from earlier
studies, including those with high risk groups [23,24,39], and is in
line with protection motivation theories of health behaviour which
outline high perceived risk of a disease as one important motivator
for initiation of risk-reducing behaviours [40].
This study had some strengths. The questions were included in a
large, monthly survey which is broadly representative of the pop-
ulation of women aged 18e74. Researcher or participant bias was
unlikely since it had been conducted by an external agency (ONS),
and consent was based on the whole survey and not a speciﬁc
module; although participants could withdraw at any time. We
adjusted analysesfor multiple testing which gives conﬁdence inthe
current ﬁndings. It also had important limitations. Because of sur-
vey constraints, women were given little information on how the
risk-stratiﬁed approach would workinpractice, and no information
on current breast screening approaches (screening modality, fre-
quency, potential harms of breast cancer screening). Knowledge of
mammography screening may vary across the population and may
affect outcomes, but this was not assessed. Furthermore, given that
some women hold very strong beliefs about breast screening, this
information may not have been sufﬁcient to elicit more in-depth
considerations about beneﬁts and harms of a risk-stratiﬁed
approach. Although we used established measures to assess read-
ability of the questions, all scenarios were hypothetical which may
have been difﬁcult to understand for some women; particularly if
English was not their ﬁrst language. Thirdly, no open questions
were used, so answers could not be explored in greater detail.
Lastly, we did not assess current screening behaviour and family
history of breast cancer which may have affected outcomes. For
example, women who reported a higher perceived risk of breast
cancer may have had a family history which would have justiﬁed
their perceptions. Future research could explore this in more detail.
However, despite the limitations, these ﬁndings give a ﬁrst indi-
cation of general attitudes towards amending a much valued
breast-screening programme.
Conclusion
The results of this study indicate that women are generally
positive towards risk-stratiﬁed mammography screening based on
Table 2
Multivariate logistic regression of predictors of attitudes to risk-stratiﬁed breast cancer screening including genetic risk.
Variable Good/very good idea (vs. bad/very bad idea/
not sure) of varying frequency of BC
screening by personal risk
Happy/very happy (vs. very unhappy/
unhappy/not sure) to have BC screening
more often if found at higher risk
Happy/very happy (vs. very unhappy/
unhappy/not sure) to have BC screening
less often if found to be at lower risk
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Age
>50 1 1 1
 50 1.17 0.88e1.58 0.280 1.25 0.84e1.85 0.273 1.18 0.89e1.57 0.228
Ethnicity
White 1 1 1
Ethnic minority 0.86 0.49e1.50 0.598 0.40 0.21e0.74 0.003 1.03 0.59e1.78 0.911
Education
University degree 1 1 1
Below university degree 0.768 0.55e1.07 0.121 0.82 0.52e1.28 0.378 0.82 0.60e1.14 0.245
Marital status
Married/cohabiting 1 1 1
Single/widowed/divorced 1.28 0.96e1.71 0.096 1.01 0.69e1.49 0.954 1.02 0.72e1.26 0.879
Perceived risk of breast cancer
b 0.83 0.66e1.05 0.135 1.71
a 1.27e2.30 <0.001 0.94 0.75e1.18 0.592
Abbreviations: BC ¼ Breast cancer, OR ¼ odds ratio, CI ¼ 95% conﬁdence interval.
Notes: Results are mutually adjusted for age, ethnicity, education, marital status, and perceived risk of breast cancer.
a Signiﬁcant after Bonferroni corrections.
b OR refers to trend for this variable.
S.F. Meisel et al. / The Breast 24 (2015) 237e241 240genetic risk assessment; although it will be important to develop
effective communication materials to minimise resistance to
reduction in screening frequency for those at lower genetic risk.
The ﬁndings give conﬁdence that the general public would support
the integration of novel genomic technologies into mainstream
healthcare.
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